Swiss (SMI) Growth Pharmaceuticals & Biotech Stocks

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
PPGN PolyPeptide Group	CHF 28.40	-7.6%	35.2%	CHF 936.3m	CHF 25.92	PS3.1x	E69.3%	0%
NWRN Newron Pharmaceuticals	CHF 8.10	-0.2%	55.8%	CHF 154.3m	CHF 14.32	PS17.9x	E51.2%	n/a
GALD Galderma Group	CHF 69.80	-0.5%	n/a	CHF 16.6b	CHF 76.80	PS4.6x	E41.7%	n/a
SANN Santhera Pharmaceuticals Holding	CHF 9.18	1.2%	12.0%	CHF 84.6m	CHF 34.50	PE1.5x	E32.5%	n/a
BSLN Basilea Pharmaceutica	CHF 39.35	-5.3%	-8.9%	CHF 475.0m	CHF 71.20	PE45.5x	E31.7%	0%
SDZ Sandoz Group	CHF 35.02	1.8%	n/a	CHF 15.0b	CHF 36.05	PE222.4x	E29.3%	1.2%
ADXN Addex Therapeutics	CHF 0.058	-3.7%	-38.7%	CHF 5.7m	n/a	PS4.1x	E23.0%	n/a
SKAN SKAN Group	CHF 76.30	-2.2%	-3.4%	CHF 1.7b	CHF 97.50	PE65.2x	E20.6%	0.5%
LONN Lonza Group	CHF 522.60	1.0%	4.2%	CHF 37.7b	CHF 586.00	PE57.7x	E20.5%	0.8%
COPN Cosmo Pharmaceuticals	CHF 69.40	2.7%	56.7%	CHF 1.1b	CHF 92.95	PS12.6x	E19.3%	2.7%
BANB Bachem Holding	CHF 86.65	2.3%	8.6%	CHF 6.5b	CHF 77.14	PE58.1x	E16.8%	0.9%
SFZN Siegfried Holding	CHF 1,006.00	1.2%	29.3%	CHF 4.3b	CHF 1,041.00	PE38.3x	E14.4%	0.4%
TECN Tecan Group	CHF 323.20	-1.9%	-8.2%	CHF 4.1b	CHF 385.71	PE31.4x	E9.2%	0.9%
NOVN Novartis	CHF 96.26	1.2%	6.1%	CHF 194.9b	CHF 101.16	PE22x	E8.8%	3.3%
ROG Roche Holding	CHF 273.50	-1.8%	0.4%	CHF 220.5b	CHF 276.53	PE19x	E8.3%	3.5%
MOLN Molecular Partners	CHF 5.60	-5.9%	2.4%	CHF 185.8m	CHF 9.35	PS27.6x	E3.3%	n/a
IDIA Idorsia	CHF 2.32	3.3%	-63.4%	CHF 418.2m	CHF 1.76	PS3x	E-8.1%	n/a
ACHI Achiko	CHF 0.0004	0%	-98.9%	CHF 58.1k	n/a	PS2.6x	n/a	n/a
KNRS Kinarus Therapeutics Holding	CHF 16.13	5.9%	-66.7%	CHF 3.9m	n/a	n/a	n/a	n/a
OBSN ObsEva	CHF 0.0012	0%	-98.2%	CHF 140.6k	n/a	PE0.02x	n/a	n/a
RLF Relief Therapeutics Holding	CHF 1.15	-1.3%	-56.0%	CHF 14.4m	n/a	PS2.4x	n/a	n/a
SPEX Spexis	CHF 0.049	-37.5%	-87.8%	CHF 3.3m	n/a	PS5.5x	n/a	n/a
KURN Kuros Biosciences	CHF 12.16	-5.7%	428.7%	CHF 451.5m	n/a	PS13.5x	n/a	n/a
DESN Dottikon ES Holding	CHF 253.00	0.2%	7.4%	CHF 3.5b	n/a	PE43.4x	S14.5%	0%